J. Raynaud

发表

Affiliations among steroid receptors as revealed by multivariate analysis of steroid binding data

J. Dore, T. Ojasoo, J. Raynaud, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

A multivariate approach to the description of patient populations. An example of the analysis of the hormone profiles of patients with advanced prostate cancer

J. Fiet, J. Dore, T. Ojasoo, 1993, The Journal of Steroid Biochemistry and Molecular Biology.

Rat estradiol binding plasma protein (EBP).

E. Baulieu, J. Raynaud, C. Mercier-Bodard, 1971, Steroids.

Correspondence factor analysis of steroid libraries

J. Dore, T. Ojasoo, J. Raynaud, 1995, Steroids.

A model for the determination of the 3D-spatial distribution of the functions of the hormone-binding domain of receptors that bind 3-keto-4-ene steroids

J. Mornon, T. Ojasoo, J. Raynaud, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts

pierre-Marie Martin, J. Raynaud, Sylvie De´los, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

5α‐reductase and 17β‐hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate

pierre-Marie Martin, J. Raynaud, F. Fina, 1998 .

Influence of rat estradiol binding plasma protein (EBP) on uterotrophic activity.

J. Raynaud, Jean-Pierre Raynaud, 1973, Steroids.

Risk assessment of antibiotic residues of beta-lactams and macrolides in food products with regard to their immuno-allergic potential.

L. Maes, C. Verschueren, J. Raynaud, 1991, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens

F. Labrie, J. Raynaud, A. Bélanger, 1983, The Prostate.

Aging Male Questionnaire in normal and complaining men.

J. Tichet, J. Fiet, J. Raynaud, 2008, The journal of sexual medicine.

Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer.

J. Fiet, J. Raynaud, M. Moguilewsky, 1986, Journal of steroid biochemistry.

The design and use of sex-steroid antagonists.

T. Ojasoo, J. Raynaud, 1986, Journal of steroid biochemistry.

High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone.

P. Camparo, T. Lebret, Y. Neuzillet, 2011, The Journal of urology.

Combined Therapy with an LHRH Agonist and an Antiandrogen in Prostatic Carcinoma

F. Labrie, J. Raynaud, A. Bélanger, 1984 .

[Androgens and prostate: basic research and clinical data].

C. Saussine, J. Tostain, D. Rossi, 2004, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Evidence for a specific mineralocorticoid receptor in rat pituitary and brain.

J. Raynaud, M. Moguilewsky, 1980, Journal of steroid biochemistry.

Prostate‐specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment

J. Gardette, J. Raynaud, J. Rollet, 2013, BJU international.

Comparison of oral versus transdermal testosterone supplementation in hypogonadal men

A. Lemaire, J. Gardette, J. Raynaud, 2010, Hormone molecular biology and clinical investigation.

Adhesiveness of a new testosterone-in-adhesive matrix patch after extreme conditions.

V. Turlier, J. Raynaud, C. Lauze, 2009, International journal of pharmaceutics.

Efficacy and safety of a new testosterone-in-adhesive matrix patch applied every 2 days for 1 year to hypogonadal men

J. Fiet, J. Raynaud, J. Rollet, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

Testosterone deficiency syndrome: Treatment and cancer risk

J. Raynaud, 2009, The Journal of Steroid Biochemistry and Molecular Biology.

Prostate cancer risk in testosterone-treated men

J. Raynaud, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

Combined long‐term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat

F. Labrie, J. Raynaud, A. Bélanger, 1982, The Prostate.

Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial)

C. Radulescu, T. Lebret, M. Rouanne, 2017, The Prostate.

Inhibition of the activity of ‘basic’ 5α-reductase (type 1) detected in DU 145 cells and expressed in insect cells

pierre-Marie Martin, J. Raynaud, S. Délos, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients

F. Hamdy, D. Chopin, P. Teillac, 1996, The Prostate.

Differences in steroid 5α-reductase iso-enzymes expression between normal and pathological human prostate tissue

D. Chopin, F. Radvanyi, S. Medina, 1999, The Journal of Steroid Biochemistry and Molecular Biology.

Sexual steroids in serum and prostatic tissue of human non‐cancerous prostate (STERPROSER trial)

C. Radulescu, T. Lebret, Y. Neuzillet, 2017, The Prostate.

Inhibition of type 1 and type 2 5α-reductase activity by free fatty acids, active ingredients of Permixon®

pierre-Marie Martin, J. Raynaud, H. Cousse, 2002, The Journal of Steroid Biochemistry and Molecular Biology.

Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence.

C. Slomianny, E. Dewailly, N. Prevarskaya, 2001, American journal of physiology. Endocrinology and metabolism.

Induction of apoptosis and inhibition of cell proliferation by the lipido‐sterolic extract of Serenoa repens (LSESr, Permixon®) in benign prostatic hyperplasia

C. Abbou, D. Chopin, M. Colombel, 2000, The Prostate.

Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon®) on rat prostate hyperplasia induced by hyperprolactinemia: Comparison with finasteride

N. Prevarskaya, F. van Coppenolle, X. Le Bourhis, 2000, The Prostate.

What is an antiandrogen and what is the physiological and pharmacological rationale for combined "castration" + "antiandrogen" therapy.

J. Raynaud, M. Moguilewsky, C. Tournemine, 1987, Progress in clinical and biological research.

Benzodiazepine activity: is interaction with the glycine receptor, as evidenced by displacement of strychnine binding, a useful criterion?

J. Raynaud, P. Hunt, 1977, The Journal of pharmacy and pharmacology.

Chapter 4 – Receptor Binding as a Tool in the Development of New Bioactive Steroids

T. Ojasoo, J. Raynaud, D. Philibert, 1979 .

Unique Steroid Congeners for Receptor Studies 1

T. Ojasoo, J. Raynaud, 2006 .

The Mechanism of Action of Anti-Hormones

J. Raynaud, 1979 .

Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.

F. Labrie, J. Raynaud, A. Lemay, 1980, International journal of fertility.

Methyltrienolone, a specific ligand for cellular androgen receptors

C. Bonne, J. Raynaud, 1975, Steroids.

[Study of the efficiency of a quantitative coproscopic technic for the routine diagnosis and control of parasitic infestations of cattle, sheep, horses and swine].

J. Raynaud, 1970, Annales de parasitologie humaine et comparee.

Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors

pierre-Marie Martin, J. Raynaud, R. Tate, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa)

O. Cussenot, Y. Allory, C. Abbou, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

The relevance of hypothalamic and hyphophyseal progestin receptor regulation in the induction and inhibition of sexual behavior in the female rat.

J. Raynaud, M. Moguilewsky, 1979, Endocrinology.

Effect of the Lipidosterolic Extract of Serenoa repens (Permixon®) and Its Major Components on Basic Fibroblast Growth Factor-Induced Proliferation of Cultures of Human Prostate Biopsies

P. Braquet, J. Mencia-Huerta, M. Paubert-Braquet, 1998, European Urology.

Comparison of the efficacy and tolerability of a new once-a-week matricial estradiol transdermal system (Estrapatch® 40 and Estrapatch® 60) with a twice week system

J. Raynaud, C. Pélissier, J. Calaf, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Spontaneous canine mammary tumour: a model for human endocrine therapy?

J. Raynaud, P. Rolland, F. André, 1981, Journal of steroid biochemistry.

Effects of progesterone and R2323 on the development of dimethylbenzanthracene-induced mammary tumors.

P. Kelly, F. Labrie, J. Raynaud, 1979, European journal of cancer.

Inhibitory effects of RU 16117, a potent estrogen antagonist, on the estrous cycle in the rat.

P. Kelly, F. Labrie, J. Raynaud, 1978, Biology of reproduction.

High inhibitory activity of R 5020, a pure progestin, at the hypothalamic-adenohypophyseal level on gonadotropin secretion.

J. Drouin, F. Labrie, J. Raynaud, 1977, Fertility and sterility.

High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.

M. Caron, P. Kelly, F. Labrie, 1977, Cancer research.

Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.

P. Kelly, F. Labrie, J. Raynaud, 1976, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Changes of pituitary sensitivity to LH-RH during the rat estrous cycle

F. Labrie, J. Raynaud, A. Léan, 1975, Molecular and Cellular Endocrinology.

[Ultrastructural localization of estradiol and moxestrol in the gonadotropic cells of rat by immunocytology after cryo-ultramicrotomy: evidence for hormonal specificity (author's transl)].

G. Morel, J. Raynaud, P. Dubois, 1981, Experientia.

Interactions between LHRH, sex steroids and inhibin in the control of LH and FSH secretion

P. Kelly, J. Drouin, F. Labrie, 1978 .

Use of melarsomine dihydrochloride (RM 340) for adulticidal treatment of dogs with naturally acquired infections of Dirofilaria immitis and for clinical prophylaxis during reexposure for 1 year.

J. Mccall, J. Raynaud, M. Dzimianski, 1994, Veterinary parasitology.

Detection and localization of 14-3-2 protein in primary cultures of embryonic rat brain

M. Cousin, J. Raynaud, J. Secchi, 1980, Brain Research.

The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review.

F. Labrie, C. Bonne, J. Raynaud, 1984, The Prostate.

Plasma renin substrate sensitivity to oestrogens and oestrogen metabolism in cirrhosis

J. Salmon, J. Ménard, F. Degos, 1978, European journal of clinical investigation.

Corticosteroid-binding globulin and corticosterone interaction with progesterone receptors

J. Raynaud, M. Moguilewsky, 1981, Nature.

Evaluation of the efficacy of salinomycin in the control of coccidiosis in chicks.

J. Raynaud, M. Naciri, P. Yvore, 1980, Poultry science.

Species differences in the biotransformation of 4-(2-methyl-3-(4-chlorobenzoyl)phenyl)butanoic acid (RU 16029).

J. Raynaud, J. Pottier, M. Busigny, 1978, Xenobiotica; the fate of foreign compounds in biological systems.

Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer.

J. Raynaud, P. Rolland, P. Martin, 1981, Cancer research.

Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men

N. Faure, F. Labrie, J. Raynaud, 1982, Journal of endocrinological investigation.

Induction of Menstruation Following Subcutaneous Injection of LH-RH and Intranasal Administration of [D-Ser(TBU) 6 des-Gly-NH 2 10 ]LH-RH Ethylamide after Ovulation in Normal Women

F. Labrie, J. Raynaud, A. Lemay, 1981 .

Inhibition of progesterone secretion during the luteal phase by two luteinizing hormone-releasing hormone agonists in Macaca fascicularis.

F. Labrie, J. Raynaud, M. Moguilewsky, 1980, Fertility and sterility.

Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women.

N. Faure, F. Labrie, J. Raynaud, 1980, Maturitas.

Luteolytic effect of intranasal administration of [D-Ser(TBU)6,DES-Gly-NH2(10)]-luteinizing hormone-releasing hormone ethylamide in normal women.

F. Labrie, J. Raynaud, A. Lemay, 1979, Fertility and sterility.

Possible luteolytic effects of luteinizing hormone-releasing hormone in normal women.

F. Labrie, J. Raynaud, A. Lemay, 1979, Fertility and sterility.

The pure antiandrogen ru 23908 (anandron®), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review

F. Labrie, C. Bonne, J. Raynaud, 1984, The Prostate.

Metabolism and protein binding of sex steroids in target organs: an approach to the mechanism of hormone action.

E. Baulieu, E. Milgrom, H. Rochefort, 1971, Recent progress in hormone research.

Progesterone-Progestin receptors.

J. Raynaud, D. Philibert, G. Azadian-Boulanger, 1974, Basic life sciences.

Androgen receptor in human skin

J. Saurat, J. Raynaud, M. Chivot, 1977, The British journal of dermatology.

Binding of [3H] methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH)

F. Labrie, C. Bonne, J. Raynaud, 1976, Steroids.

Assay of androgen binding sites by exchange with methyltrienolone (R 1881)

C. Bonne, J. Raynaud, 1976, Steroids.

Comparative binding specificity of methyltrienolone in human and rat prostate.

C. Bonne, J. Raynaud, R. Tremblay, 1976, Hormone research.

11β-substituted steroids, an original pathway to antihormones

G. Teutsch, T. Ojasoo, J. Raynaud, 1988 .

Mode of spironolactone anti-androgenic action: inhibition of androstanolone binding to rat prostate androgen receptor.

C. Bonne, J. Raynaud, 1974, Molecular and cellular endocrinology.

Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum

J. Raynaud, P. Hunt, M. Kannengiesser, 1974, The Journal of pharmacy and pharmacology.

Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.

J P Raynaud, T Ojasoo, J. Dore, 1988, Journal of medicinal chemistry.

Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis.

P. Boyle, F. Hamdy, F. Debruyne, 2004, European urology.

Long-term clinical and biologic effects of the lipidosterolic extract ofSerenoa repens in patients with symptomatic benign prostatic hyperplasia

A. Vinarov, J. Raynaud, N. Lopatkin, 2002 .

[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].

P. Boyle, F. Hamdy, F. Debruyne, 2002, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Steroid flexibility and receptor specificity.

J P Raynaud, T Ojasoo, J. Delettré, 1980, Journal of steroid biochemistry.

Long-term effects of prenatal oestrogen treatment on genital morphology and reproductive function in the rat.

J. Raynaud, B. Vannier, 1980, Journal of reproduction and fertility.

Influence of Rat Estradiol Binding Plasma Protein (EBP) on Estrogen Binding to its Receptor and on Induced Biological Responses

J. Raynaud, B. Vannier, M. Moguilewsky, 1980 .

Major internal parasites interfering with cattle production in France, and experiments to control them by strategic treatments. A bibliographic review.

J. Raynaud, C. Mage, J. P. Le Stang, 1981, Annales de recherches veterinaires. Annals of veterinary research.

Pharmacokinetics of oxytetracycline in young cattle: comparison of conventional vs long-acting formulations.

P. Toutain, J. Raynaud, 1983, American journal of veterinary research.

Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man.

P. Kelly, F. Labrie, G. Pelletier, 1980, International journal of fertility.

Multivariate analysis of plasma hormones in patients with metastatic prostate cancer receiving combined LHRH‐analog and antiandrogen therapy

J. Fiet, J. Dore, T. Ojasoo, 1993, The Prostate.

New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogen.

F. Labrie, J. Raynaud, A. Bélanger, 1983, Journal of steroid biochemistry.

Inhibitory effects of a single intranasal administration of [D-Ser(TBU)6, des-Gly-NH210]LHRH ethylamide, a potent LHRH agonist, on serum steroid levels in normal adult men.

F. Labrie, J. Raynaud, A. Lemay, 1980, Journal of steroid biochemistry.

Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and function.

P. Kelly, F. Labrie, J. Raynaud, 1979, Advances in experimental medicine and biology.

Experimental models for respiratory diseases of ruminants and of swine

J. Raynaud, J. Espinasse, F. Osdoit, 1983 .

Pharmacokinetics of the anti-inflammatory tiaprofenic acid in humans, mice, rats, rabbits, and dogs.

J. Raynaud, J. Pottier, D. Berlin, 1977, Journal of pharmaceutical sciences.

Pharmacokinetic study of a peripheral analgesic, floctafenin, in man, mouse, rat, and dog.

J. Raynaud, J. Pottier, M. Busigny, 1975, Drug metabolism and disposition: the biological fate of chemicals.

Steroid hormone receptors and pharmacology.

J. Mornon, F. Labrie, T. Ojasoo, 1980, Journal of steroid biochemistry.

Hydrophobic cluster analysis (HCA) of the hormone-binding domain of receptor proteins.

J P Raynaud, T Ojasoo, J. Mornon, 1989, Journal of steroid biochemistry.

Adrenocorticotropin analogs and glucocorticoids in the hypophysectomized rat. II. Effects on cerebral cortex polyribosomes.

J. Raynaud, D. Lando, 1980, Endocrinology.

(DE)PHOSPHORYLATION AGENTS INFLUENCE 5α-REDUCTION OF TESTOSTERONE IN HUMAN PROSTATE

J. M. Goff, J. Raynaud, P. Martin, 1988 .

The relevance of interaction kinetics in determining biological response to estrogens.

J. Raynaud, M. Bouton, 1979, Endocrinology.

Comparative study of estrogen action.

J P Raynaud, M M Bouton, J. Raynaud, 1973, Molecular pharmacology.

CHAPTER 11 – Chemical Substitution of Steroid Hormones: Effect on Receptor Binding and Pharmacokinetics

J. Salmon, T. Ojasoo, J. Raynaud, 1982 .

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.

F. Labrie, Y. Lacourciére, J. Raynaud, 1982, Clinical and investigative medicine. Medecine clinique et experimentale.

Contraception with LHRH agonists, a new physiological approach.

P. Kelly, F. Labrie, G. Pelletier, 1981, Reproduccion.

Inhibition of 5 -reductase activity of rat prostate by estradiol derivatives.

C. Bonne, J. Raynaud, 1973, Biochimie.

Steroid hormones—agonists and antagonists

F. Labrie, T. Ojasoo, J. Raynaud, 1981 .

A "proportion graph" method for measuring binding systems.

J P Raynaud, E. Baulieu, J. Raynaud, 1970, European journal of biochemistry.

Effect of estrogen plasma binding on sexual differentiation of the rat fetus

J. Raynaud, B. Vannier, 1975, Molecular and Cellular Endocrinology.

Pharmacokinetic study of a new testosterone-in-adhesive matrix patch applied every 2 days to hypogonadal men

A. Beckers, J. Raynaud, V. Gualano, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

Comparative action of fenfluramine on the uptake and release of serotonin and dopamine.

J. Raynaud, P. Hunt, M. Kannengiesser, 1976, European journal of pharmacology.

Dopamine uptake inhibitors and releasing agents differentiated by the use of synaptosomes and field-stimulated brain slices in vitro.

J. Raynaud, U. Schacht, P. Hunt, 1979, Biochemical pharmacology.

Towards the mapping of the progesterone and androgen receptors.

J P Raynaud, T Ojasoo, J. Delettré, 1987, Journal of steroid biochemistry.

Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues.

F. Labrie, C. Bonne, J. Raynaud, 1979, Journal of steroid biochemistry.

Characterization and hormonal control of the androgen receptor in the hamster sebaceous glands.

C. Bonne, J. Raynaud, 1977, The Journal of investigative dermatology.

Stability of 70S ribosomes in relation to misreading and antibacterial activity of aminoglycosides.

M. Cousin, T. Ojasoo, J. Raynaud, 1977, Biochimie.

Estrogen-sensitive progestin-binding sites in the female rat brain and pituitary

J. Raynaud, M. Moguilewsky, 1979, Brain Research.

RU 16117, an orally active estriol-like weak estrogen.

P. Kelly, N. Faure, F. Labrie, 1984, Journal of steroid biochemistry.

[Post-natal parasitic infection of piglets in contact with infected mothers. a study of 20 sows and 164 piglets, 42 of which were killed at weaning (author's transl)].

J. Raynaud, E. Irisarri, J. Sennelier, 1975, Folia veterinaria Latina.

A new approach to estrogen-free contraception based on progesterone receptor blockage by mid-cycle administration of ethyl norgestrienone (R 2323).

J. Raynaud, F. Laraque, E. Sakiz, 1974, Contraception.

Progesterone binding in the immature mouse and rat uterus.

J. Raynaud, D. Philibert, 1973, Steroids.

Progesterone binding in the immature rabbit and guinea pig uterus.

J. Raynaud, D. Philibert, 1974, Endocrinology.

Stable and Specific Tracers

T. Ojasoo, J. Raynaud, V. Vaché, 1981 .

Properties of the cytoplasmic progestin-binding protein in the rabbit uterus.

T Ojasoo, T. Ojasoo, J. Raynaud, 1977, Endocrinology.

Progestin binding sites in the rat hypothalamus pituitary and uterus

J. Raynaud, M. Moguilewsky, 1977, Steroids.

Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors

P. Kelly, F. Labrie, J. Raynaud, 1976, Steroids.

SCREENING FOR ANTI-HORMONES BY RECEPTOR STUDIES

C. Bonne, J. Raynaud, D. Philibert, 1976 .

Steroid binding in the hypothalamus and pituitary.

J. Raynaud, D. Philibert, B. Vannier, 1976, Current topics in molecular endocrinology.

Screening for anti-hormones by receptor studies.

C. Bonne, J. Raynaud, D. Philibert, 1975, Journal of steroid biochemistry.

Binding of progesterone and R 5020, a highly potent progestin, to human endometrium and myometrium.

J. Raynaud, D. Philibert, Jean-Pierre Raynaud, 1974, Contraception.

Estradiol binding of exceptionally high affinity by a nonhistone chromatin protein fraction.

E. Baulieu, J. Raynaud, N. Massol, 1971, Biochemistry.

Antidopaminergic activity of estrogens on prolactin release at the pituitary level in vivo

F. Labrie, J. Raynaud, L. Ferland, 1979, Molecular and Cellular Endocrinology.

The relationship between glucocorticoid structure and effects upon thymocytes.

D. Duval, J. Raynaud, P. Meyer, 1977, Molecular pharmacology.

Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH).

F. Labrie, C. Bonne, J. Raynaud, 1979, Journal of steroid biochemistry.

Unique steroid congeners for receptor studies.

T. Ojasoo, J. Raynaud, 1978, Cancer research.

110. In vitro screening for anti-hormones

C. Bonne, J. Raynaud, M. Bouton, 1978 .

11β-Methoxy-17-ethynyl-1,3,5(10)-estratriene-3,17β-diol (Moxestrol), a Tag for Estrogen Receptor Binding Sites in Human Tissues

T. Ojasoo, J. Raynaud, M. Bouton, 1978 .

The relevance of kinetic parameters in the determination of specific binding to the estrogen receptor.

J. Raynaud, M. Bouton, 1978, Journal of steroid biochemistry.

Progesterone receptors in normal and neoplastic tissues

W. McGuire, E. Baulieu, J. Raynaud, 1977 .

Receptors in Breast Cancer: An Introduction

J. Raynaud, 1977, Annals of the New York Academy of Sciences.

Progesterone receptors: introduction and overview.

W. McGuire, E. Baulieu, J. Raynaud, 1977 .

a Tag for EstrogenReceptorBindingSites in HumanTissues

T. Ojasoo, J. Raynaud, M. Bouton, 1978 .

Action of midcycle contraceptive (R 2323) on the human endometrium.

J. Raynaud, F. Laraque, J. Secchi, 1976, American journal of obstetrics and gynecology.

Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.

M. Caron, P. Kelly, F. Labrie, 1977, Journal of the National Cancer Institute.

Estradiol Receptors in the Uterus

E. Baulieu, H. Rochefort, J. Raynaud, 1971 .

Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain

F. Labrie, J. Raynaud, T. Paolo, 1979, Molecular and Cellular Endocrinology.

[1st isolation of Toxoplasma gondii in Madagascar. Spontaneous and experimental toxoplasmosis in Lemur catta].

P. Sureau, É. Brygoo, J. Raynaud, 1962, Bulletin de la Societe de pathologie exotique et de ses filiales.

Development of a highly sensitive and specific new testosterone time-resolved fluoroimmunoassay in human serum

A. Valleix, J. Fiet, H. Galons, 2004, Steroids.

Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading

C. Radulescu, T. Lebret, Y. Neuzillet, 2015, Prostate Cancer and Prostatic Disease.

Obesity and hypogonadism are associated with an increased risk of predominant Gleason 4 pattern on radical prostatectomy specimen

C. Radulescu, T. Lebret, Y. Neuzillet, 2015, Hormone molecular biology and clinical investigation.

Serum bioavailable testosterone: assayed or calculated?

D. Chopin, J. Fiet, J. Raynaud, 2006, Clinical chemistry.

Highly sensitive and specific time-resolved fluoroimmunoassay (TR-FIA) of cyproterone acetate and free cyproterone

J. Fiet, H. Galons, J. Raynaud, 2000, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of new hydroxylated triphenylethylene (TPE) derivatives on estradiol binding to uterine cytosol.

T. Ojasoo, J. Raynaud, A. Crastes de Paulet, 1984, Journal of steroid biochemistry.

Correspondence analysis applied to steroid receptor binding.

J P Raynaud, T Ojasoo, J. Dore, 1986, Journal of medicinal chemistry.

An in vitro model for the study of psychotropic drugs and as a criterion of antidepressant activity.

J. Raynaud, P. Hunt, M. Kannengiesser, 1973, Biochemical pharmacology.

Comparison between tracer calves and herbage samplings for the assessment of pasture infectivity in trichostrongylosis of cattle.

J. Raynaud, J. Cabaret, J. P. Le Stang, 1982, Veterinary parasitology.

Bovine ostertagiosis, a review. Analysis of types and syndromes found in France by post mortem examinations and total worm counts.

J. Raynaud, A. Bouchet, 1976, Annales de recherches veterinaires. Annals of veterinary research.

The nature of (3H)imipramine binding to synaptosomes.

J. Raynaud, P. Hunt, M. Kannengiesser, 1975, Biochemical pharmacology.

Clinical prophylactic activity of melarsomine dihydrochloride (RM 340) against Dirofilaria immitis in heartworm-naive beagles exposed to natural infection in three southeastern states.

J. Mccall, J. Raynaud, M. Dzimianski, 1994, Veterinary parasitology.

Diagnostic expérimental des helminthoses animales

J. Raynaud, 1982 .

Thiacetarsamide (adulticide) versus melarsomine (RM 340) developed as macrofilaricide (adulticide and larvicide) to cure canine heartworm infection in dogs.

J. Raynaud, 1992, Annales de recherches veterinaires. Annals of veterinary research.

Pulmonary thromboembolism and hypertension after thiacetarsamide vs melarsomine dihydrochloride treatment of Dirofilaria immitis infection in dogs.

C. Rawlings, J. Raynaud, R. Lewis, 1993, American journal of veterinary research.

Feasibility of herbage sampling in large extensive pastures and availability of cattle nematode infective larvae in mountain pastures.

J. Raynaud, L. Gruner, 1982, Veterinary parasitology.

Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels

F. Labrie, J. Raynaud, T. Paolo, 1980, Neuropharmacology.

Pharmacokinetics and metabolism of moxestrol in humans.

J. Salmon, J. Raynaud, C. Cousty, 1983, Journal of steroid biochemistry.

Relative involvement of protein kinase C and of the estrogen receptor in the cytotoxic action of a population of triphenylethylenes on MCF7 cells as revealed by correspondence factorial (CF) analysis

J. Dore, T. Ojasoo, J. Raynaud, 1993, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of di- and tri-phenylethylene estrogen/antiestrogen structure on the mechanisms of protein kinase C inhibition and activation as revealed by a multivariate analysis.

J. Dore, T. Ojasoo, J. Raynaud, 1991, Biochemical pharmacology.

Effect of triphenylacrylonitrile derivatives on estradiol-receptor binding and on human breast cancer cell growth.

J. Abecassis, J. Dore, T. Ojasoo, 1989, Journal of medicinal chemistry.

Hydroxylated triphenylacrylonitriles adopt a unique orientation within the binding site of the estrogen receptor.

T. Ojasoo, J. Raynaud, A. Crastes de Paulet, 1990, Journal of steroid biochemistry.

[Total elbow joint allograft for long term posttraumatic osteoarticular loss. Follow-up results at twelve years].

Y. Allieu, J. Raynaud, M. Chammas, 2004, Revue de chirurgie orthopedique et reparatrice de l'appareil moteur.

A radioreceptor assay for benzodiazepines

J. Raynaud, J. Husson, P. Hunt, 1979, The Journal of pharmacy and pharmacology.

Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent issues in the rat

P. Kelly, F. Labrie, J. Raynaud, 1981, Molecular and Cellular Endocrinology.

LH-RH Agonists: Inhibition of Testicular Functions and Possible Clinical Applications

P. Kelly, F. Labrie, G. Pelletier, 1980 .

The use of interaction kinetics to distinguish potential antagonists from agonists

T. Ojasoo, J. Raynaud, M. Bouton, 1980 .

Multivariate analysis by the minimum spanning tree method of the structural determinants of diphenylethylenes and triphenylacrylonitriles implicated in estrogen receptor binding, protein kinase C activity, and MCF7 cell proliferation.

J P Raynaud, T Ojasoo, J. Dore, 1992, Journal of medicinal chemistry.

Recent Studies on the Feedback Control of Acth Secretion, with Particular Reference to the Role of Transcortin in Pituitary‐Thyroid‐Adrenocortical Interactions

F. Labrie, G. Pelletier, J. Raynaud, 2008 .

Adrenocorticotropin analogs and glucocorticoids in the hypophysectomized rat. I. Effects on liver polyribosomes and rough endoplasmic reticulum.

J. Raynaud, J. Secchi, J. Roche, 1980, Endocrinology.

Method of evaluating the efficiency of anticoccidial drugs in floor-pen trials with multiple in-feed infection versus "seeding" model.

J. Raynaud, M. Virat, M. Naciri, 1980, Annales de recherches veterinaires. Annals of veterinary research.

Animal models for hormone-dependent human breast cancer

J. Raynaud, F. André, J. Mialot, 2004, Cancer Chemotherapy and Pharmacology.

Effects of estrogens on renin substrate and uterine weights in rats.

J. Ménard, P. Corvol, J. Raynaud, 1973, Endocrinology.

Pharmacokinetics and metabolism of moxestrol in animals--rat, dog and monkey.

J. Salmon, J. Raynaud, C. Cousty, 1983, Journal of Steroid Biochemistry.

Reference compounds for the study op moxestrol metabolism

J. Salmon, J. Raynaud, C. Cousty, 1979, Steroids.

Double‐Blind Crossover Clinical Pharmacology Study Comparing Moxestrol (R 2858) and Ethinyl Estradiol in Postmenopausal Women

M. Rozencweig, M. Vekemans, J. Raynaud, 1978, Journal of clinical pharmacology.

Preoperative low serum testosterone levels are associated with tumor aggressiveness in radical prostatectomy treated cancer patients

P. Camparo, T. Lebret, Y. Neuzillet, 2010, Hormone molecular biology and clinical investigation.

Determination of bioavailable testosterone [non sex hormone binding globulin (SHBG)-bound testosterone] in a population of healthy French men: influence of androstenediol on testosterone binding to SHBG.

J. Tichet, S. Urien, J. Fiet, 2007, Clinical chemistry.

4. Steroid catabolism121. Metabolic studies of R2453, a highly potent progestin

J. Salmon, J. Raynaud, C. Cousty, 1974 .

INTERACTIONS OF OESTRADIOL BENZOATE AND PROMEGESTONE UPON BASAL AND TRH‐INDUCED PROLACTIN SECRETION IN POSTMENOPAUSAL WOMEN

J. Raynaud, G. Schaison, B. Couzinet, 1986, Clinical endocrinology.

Non-michaelian behavior of 5α-reductase in human prostate

J. M. Goff, T. Ojasoo, J. Raynaud, 1989 .

Comparison of Techniques for Assessment of the Contamination of Pasture Herbage with Infective Nematode Larvae

J. Raynaud, L. Gruner, 1981 .

Simplified technique for taking herbage samples and counting the larvae of parasitic nematodes in order to assess the infestation of cattle pastures.

J. Raynaud, L. Gruner, 1980 .

Measurement of steroid binding proteins.

E. Baulieu, E. Milgrom, J. Raynaud, 1970, Acta endocrinologica. Supplementum.

Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy

M. Rouprêt, T. Lebret, M. Rouanne, 2021, Asian journal of andrology.

Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy

M. Rouprêt, T. Lebret, M. Rouanne, 2021, Asian journal of andrology.

Inhibition of prostaglandin synthetase by di- and triphenylethylene derivatives: a structure-activity study.

J. Raynaud, A. Crastes de Paulet, G. Précigoux, 1983, Journal of medicinal chemistry.

Two Approaches to Structure-Activity Relationships in the Field of Sex-Steroids and Their Analogs

J. Mornon, J. Dore, T. Ojasoo, 2018 .

Evaluation on 5500 young pigs of Carbadox1 used at 50 ppm. Economic interpretation in reference with performances of control animals or supplements used at nutritional (≤ 150 ppm) or therapeutic (≥ 200 ppm) levels

J. Raynaud, 2009 .

Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.

A. Zlotta, P. Teillac, J. Raynaud, 2005, European urology.

Assessment of filaricidal activity of a new filaricide (RM 340) against immature and adult heartworms using experimental canine models.

J. Mccall, J. Raynaud, M. Dzimianski, 1989 .

Swine dysentery. Comparison of experimental diseases produced by infection with colonic mucosa or with Treponema hyodysenteriae, French strains, and of "natural" disease.

J. Raynaud, J. Philippe, G. Brunault, 1980, Annales de recherches veterinaires. Annals of veterinary research.

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.

P. Boyle, F. Hamdy, F. Debruyne, 2002, European urology.

[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].

P. Boyle, F. Hamdy, F. Debruyne, 2004, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia.

A. Vinarov, J. Raynaud, N. Lopatkin, 2002, Advances in therapy.

Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results

P. Validire, M. Rouprêt, C. Radulescu, 2018, Hormones and Cancer.

PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study

M. Rouprêt, T. Lebret, Y. Neuzillet, 2021, World Journal of Urology.

The use of the morantel sustained release bolus under special farm practices (deprime system) in France.

J. Raynaud, P. Lockwood, J. P. Le Stang, 1983, Veterinary parasitology.

The control of parasitic gastroenteritis of grazing cattle in Normandy, France using the morantel sustained release bolus.

J. Raynaud, R. Jones, D. Kerboeuf, 1983, Veterinary parasitology.

Biotransformations of glafenine in the rat and in man

J. Raynaud, J. Pottier, M. Busigny, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist.

F. Labrie, J. Raynaud, A. Bélanger, 1983, Hormone research.

Effectiveness of carbadox at 50 PPM on the performance of the young pig: methodology and influence of the initial weight.

J. Raynaud, A. Aumaitre, 2009, Zeitschrift fur Tierphysiologie, Tierernahrung und Futtermittelkunde.

Dictyocaulus viviparus in calves: quantitation of antibody activities in sera and respiratory secretions by immuno-enzymatic analysis.

J. Raynaud, P. Péry, G. Luffau, 1979, Annales de recherches veterinaires. Annals of veterinary research.

Endocrine effects of Gestrinone

L. Martini, T. Ojasoo, J. Raynaud, 1984 .

Binding of Estradiol and other Estrogens to Castrated Rat and Prepuberal Sow Endometrium Proteins

E. Baulieu, H. Richard-Foy, H. Rochefort, 1969 .